Gastrointestinal adverse events were prominent in the retatrutide obesity program. Studies generally report the type of event and how frequently it was observed in each group.
Frequency, severity and discontinuation
Frequency, intensity and treatment discontinuation are distinct outcomes. An event can be common while a smaller proportion of participants stop treatment because of it.
How to interpret the evidence
Use the same definition and denominator when comparing event rates across trial groups.
This research summary focuses on a defined endpoint or safety observation. Its relevance depends on the study’s population and follow-up.